Literature DB >> 9671009

Differences between local investigator and core laboratory interpretation of the admission electrocardiogram in patients with unstable angina pectoris or non-Q-wave myocardial infarction (a Thrombin Inhibition in Myocardial Ischemia [TRIM] substudy).

L Holmvang1, P Hasbak, P Clemmensen, G Wagner, P Grande.   

Abstract

The present study compares the on-site interpretation of an admission electrocardiogram (ECG) with core laboratory results in a large, multicenter trial of 516 patients diagnosed with unstable angina pectoris or non-Q-wave myocardial infarction. The local investigators evaluated the admission ECG regarding ST-T changes before the ECGs were sent to the core laboratory for blinded interpretation. The strength of agreement between the observations was described by kappa statistics. There was a poor agreement regarding identification of ST-segment elevation, with 17 patients identified by the local investigator versus 92 by the core laboratory (kappa = 0.05). There was a fair agreement on ST-segment depression with 158 patients diagnosed on-site versus 64 by the core laboratory (kappa = 0.38). Identification of T-wave inversion demonstrated good agreement with 306 patients diagnosed on-site versus 280 by the core laboratory (kappa = 0.63). A moderate agreement regarding identification of a normal ECG was found with 101 patients on-site versus 135 in the core laboratory (kappa = 0.42). Independent variables, including peak creatine kinase-MB and 30-day outcome, were more closely related to core laboratory results than the local investigator's interpretation of the admission ECG. Thus, in the present study, considerable differences were demonstrated between the on-site interpretation of the admission ECG and the blinded evaluation performed in the core laboratory regarding relatively simple electrocardiographic variables. The results suggest that more widespread use of independent evaluation of clinical data should be incorporated in future clinical trials.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671009     DOI: 10.1016/s0002-9149(98)00226-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Observer variability in ECG interpretation for thrombolysis eligibility: experience and context matter.

Authors:  David Massel
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

2.  Interhospital observer agreement in interpretation of exercise myocardial Tc-99m tetrofosmin SPECT studies.

Authors:  J Candell-Riera; C Santana-Boado; B Bermejo; L Armadans; J Castell; I Casáns; J Jurado; J Magriñá; J N de la Rosa
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

3.  Accuracy of cardiogoniometry compared with electrocardiography in the diagnosis of coronary artery disease.

Authors:  Behshid Ghadrdoost; Majid Haghjoo; Ata Firouzi
Journal:  Res Cardiovasc Med       Date:  2015-02-20

4.  The value of core lab stress echocardiography interpretations: observations from the ISCHEMIA Trial.

Authors:  Akihisa Kataoka; Marielle Scherrer-Crosbie; Roxy Senior; Gilbert Gosselin; Denis Phaneuf; Gabriela Guzman; Gian Perna; Alfonso Lara; Sasko Kedev; Andrea Mortara; Mohammad El-Hajjar; Leslee J Shaw; Harmony R Reynolds; Michael H Picard
Journal:  Cardiovasc Ultrasound       Date:  2015-12-18       Impact factor: 2.062

5.  Automatic Triage of 12-Lead ECGs Using Deep Convolutional Neural Networks.

Authors:  Rutger R van de Leur; Lennart J Blom; Efstratios Gavves; Irene E Hof; Jeroen F van der Heijden; Nick C Clappers; Pieter A Doevendans; Rutger J Hassink; René van Es
Journal:  J Am Heart Assoc       Date:  2020-05-14       Impact factor: 5.501

Review 6.  Golden Standard or Obsolete Method? Review of ECG Applications in Clinical and Experimental Context.

Authors:  Tibor Stracina; Marina Ronzhina; Richard Redina; Marie Novakova
Journal:  Front Physiol       Date:  2022-04-25       Impact factor: 4.755

Review 7.  Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons.

Authors:  Anna Meta Dyrvig Kristensen; Manan Pareek; Kristian Hay Kragholm; Thomas Steen Gyldenstierne Sehested; Michael Hecht Olsen; Eva Bossano Prescott
Journal:  Cardiology       Date:  2022-05-10       Impact factor: 2.342

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.